Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederik Giesel

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Rheumatology (Oxford, England)|April 22, 2024
Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remissionManuel Röhrich, Juan J Rosales, Jorge Hoppner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2019
Development of Novel PSMA Ligands for Imaging and Therapy with Copper IsotopesJosé Carlos Dos Santos, Barbro Beijer, Ulrike Bauder-Wüst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2019
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: <sup>64</sup>Cu- and <sup>225</sup>Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse ModelsTadashi Watabe, Yuwei Liu, Kazuko Kaneda-Nakashima, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 26, 2023
The Role of Alternative Lymph Node Classification Systems in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Superiority of a LODDS Scheme Over N Category in Pancreatic NEN (pNEN)Sarah Krieg, Johannes Tunk, Sascha Vaghiri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with <sup>213</sup>Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic TumorsAndreas Helisch, Clemens Kratochwil, Christian Kleist, et al.
Nuklearmedizin. Nuclear Medicine|June 17, 2020
[Structured reporting in oncologic hybrid imaging: a consensus recommendation]Thorsten Derlin, Sergios Gatidis, Bernd Joachim Krause, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2017
Simultaneous whole-body <sup>18</sup>F-PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot studyMartin T Freitag, Claudia Kesch, Jens Cardinale, et al.
EJNMMI Reports|November 7, 2024
Enhancing the diagnostic capacity of [<sup>18</sup>F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory studyPhilip Alexander Glemser, Martin Freitag, Balint Kovacs, et al.
European Urology|December 15, 2020
Salvage Surgery in Patients with Local Recurrence After Radical ProstatectomySophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al.
British Journal of Cancer|July 3, 2018
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trialAnne Katrin Berger, Stephan Lücke, Ulrich Abel, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|April 22, 2024
Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remissionManuel Röhrich, Juan J Rosales, Jorge Hoppner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2019
Development of Novel PSMA Ligands for Imaging and Therapy with Copper IsotopesJosé Carlos Dos Santos, Barbro Beijer, Ulrike Bauder-Wüst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 6, 2019
Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: <sup>64</sup>Cu- and <sup>225</sup>Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse ModelsTadashi Watabe, Yuwei Liu, Kazuko Kaneda-Nakashima, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 26, 2023
The Role of Alternative Lymph Node Classification Systems in Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NEN): Superiority of a LODDS Scheme Over N Category in Pancreatic NEN (pNEN)Sarah Krieg, Johannes Tunk, Sascha Vaghiri, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with <sup>213</sup>Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic TumorsAndreas Helisch, Clemens Kratochwil, Christian Kleist, et al.
Nuklearmedizin. Nuclear Medicine|June 17, 2020
[Structured reporting in oncologic hybrid imaging: a consensus recommendation]Thorsten Derlin, Sergios Gatidis, Bernd Joachim Krause, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2017
Simultaneous whole-body <sup>18</sup>F-PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot studyMartin T Freitag, Claudia Kesch, Jens Cardinale, et al.
EJNMMI Reports|November 7, 2024
Enhancing the diagnostic capacity of [<sup>18</sup>F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory studyPhilip Alexander Glemser, Martin Freitag, Balint Kovacs, et al.
European Urology|December 15, 2020
Salvage Surgery in Patients with Local Recurrence After Radical ProstatectomySophie Knipper, Luigi Ascalone, Benjamin Ziegler, et al.
British Journal of Cancer|July 3, 2018
Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trialAnne Katrin Berger, Stephan Lücke, Ulrich Abel, et al.
Pageof 7